Advisory Board and Editors Toxicology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Yasmina M Abd-Elhakim

Prof. Dr. Yasmina Mohammed Abd-Elhakim is a Professor in the Forensic Medicine and Toxicology Department in the Faculty of Veterinary Medicine, Zagazig University, Egypt. Her major area of expertise is the use of eco-friendly mitigation strategies to combat the hazards of environmental pollutants. Additionally, she has a special interest in the therapeutic uses of arthropods venoms, particularly in neurodegenerative diseases and cancer. She has 60 papers in prestigious international journals and 2 book chapters, h-index 19, and more than 1000 citations based on the Scopus database. She reviewed about 870 manuscripts for highly impacted journals in the field of toxicology and environmental pollution based on the Publon database. She has been included in the editorial board of several highly impacted international journals. She received various awards including The Egyptian State Encouragement Award in "Agricultural sciences" in 2019, the Publons peer reviewer award as a Top Reviewers for Pharmacology & Toxicology in 2018 and 2019, and the international publication's award from Zagazig University (2015-2019).

Aniruddha Adhikari

Dr. Adhikari is a highly accomplished Biochemist currently associated with University of California at Los Angeles (UCLA), USA. Dr. Adhikari's research is focused on the development of nanohybrid drug delivery systems and nanomedicines for the treatment of chronic diseases. His particular focus was to explore the therapeutic potential of nanomaterials against chronic diseases where redox modulation plays a crucial role with an emphasis on their molecular mechanism of action including bio-molecular interactions, toxicity, pharmacokinetics and pharmacodynamics. Dr. Adhikari's seminal work on the chemoprevention of bilirubin encephalopathy has led to the discovery of a new and groundbreaking one-of-its-kind nanomedicine, which is currently under phase 2 clinical trial. His current research interest includes bacteriophage mediated nanotherapy and stimuli-responsive antibody conjugated nanomaterials.

Dr. Adhikari has received numerous prestigious national and international awards and grants for his research contributions. Most notable ones are Gandhian Young Technological Innovation (GYTI) Award/Appreciation from the Rashtrapati Bhavan (Office of the President, Republic of India), DMM Travel Grant from Company of Biologists, UK, Nano-challenge Award, Indo-US and four GRC Travel Grants from Gordon Research Conference, USA.

Dr. Adhikari's research contributions are widely acknowledged, and in his short research career span of about seven years he has published more than 50 research articles in high-impact prestigious international peer-reviewed journals (h-index: 13, i-10 index: 17), filed 3 patents, delivered lectures in 16 international conferences. Additionally, he has twice served as the discussion leader at Gordon Research Seminar (GRS). He also serves as the Editorial Board member and reviewer of various journals.

Fares E.M Ali

Dr. Fares E.M Ali is an Assistant Professor within the Pharmacology and Toxicology Department, Al-Azhar University, Assiut, Egypt. Fares primary research interests include Hepatology, Gastroenterology, Clinical Pharmacology, Toxicology, and Nephrology. Their current projects are 'Cholestatic liver injury: new vision, renal fibrosis management, and overcoming cancer chemotherapy adverse effects.

Mehmet Burak Ateş

Dr. Mehmet Burak ATEŞ is a researcher supporting the integration of innovative educational technology for clinical teaching and learning in veterinary health sciences.
His special interests are veterinary pathology, experimental pathology, toxicopathology, molecular pathology, molecular oncology, liver and brain pathology.
Dr. Ateş's portfolio includes a wide range of scientific articles in peer-reviewed journals, books, and conference proceedings published.

Thomas Backhaus

Professor for Ecotoxicology and Environmental Sciences at the University of Gothenburg, with a main interest in regulatory (eco)toxicology and risk assessment of complex exposure situations.

Emanuel Carrilho

Dr. Carrilho obtained his B.Sc. in Chemistry and M.Sc. in Analytical Chemistry from the University of São Paulo (USP) at São Carlos, Brazil, in 1987 and 1990, respectively. In 1997 he obtained his Ph.D. at the Northeastern University under the mentoring of Professor Barry L. Karger, from the Barnett Institute, in Boston, MA. He joined the faculty of the analytical chemistry program of the Institute of Chemistry at São Carlos, USP in 1998 where is full professor. During 2007-2009 he was a visiting professor at Harvard University in Professor George M. Whitesides group.

Dr. Carrilho’s group has been working on the development of new bioanalytical methods covering the broad aspects of genomics, proteomics, metabolomics for human health and applied microbiology in the search for cancer biomarkers and neglected tropical diseases. In the process translate the targeted biomarkers research to microfluidic platforms with biosensors and microchip electrophoresis for point-of-care applications. Recently, is developing microfluidic applications for low-cost diagnostics for developing countries using paper-based analytical devices (µPADs).

Minjun Chen

Minjun Chen is a principal investigator working at the Division of Bioinformatics and Biostatics of the US FDA’s National Center for Toxicological Research and serve as the adjunct faculty and mentor for the bioinformatics program joint by Univ. of Arkansas at Little Rock (UALR) and Univ. of Arkansas for Medical Sciences (UAMS). Currently, he co-chairs the FDA Liver Toxicity Working Group since 2014 and is the editor of the Springer book titled “Drug-induced Liver Toxicity”. His primary research interests encompass drug-induced liver injury, drug safety, bioinformatics, and personalized medicine. He has authored or co-authored more than 80 scientific publications and book chapters.

Kevin M. Crofton

Research Toxicologist and Acting Deputy Director of the National Center for Computational Toxicology at the US Environmental Protection Agency. Adjunct Assistant Professor in the Department of Toxicology at North Carolina State University and the Curriculum in Toxicology, University of North Carolina at Chapel Hill.

Wei Cui

Wei CUI, Ph.D.
Extension Assistant Professor
Principal Investigator (Independent)
Director, Animal Models Core Facility

at University of Massachusetts Amherst

More than 14 years of experience in mammalian oocyte and pre-implantation embryo development. Created live transgenic cloned goats by somatic cell nuclear transfer (SCNT). Generated multiple Knockout and Knock-in rat and mouse lines by ZFN, TALEN, and CRISPR/Cas9.

Academic Editor for PeerJ;
Associate Editor for Journal of Cellular and Molecular Medicine;
Associate Editor for Reproduction and Fertility;
Associate Editor for Animal Reproduction-Theriogenology, Frontiers in Veterinary Science;
Academic Editor for PLOS ONE.

Served as Peer Reviewer for more than 40 journals 170 times, as well as Editors for over 40 times.

Keywords: Mammalian oogenesis, Preimplantation Embryo, Oocyte maturation, CRISPR/Cas9, Knockout, Knock-in, Oocyte-specific conditional knockout, Somatic Cell Nuclear Transfer (SCNT), Oocyte spontaneous activation, Cell cycle, Oocyte aging, Animal models, Epigenetics, Toxicology, Cell culture, Fertilization, Micromanipulation, RNAi, Knockdown, Animal reproduction, Genome editing, Blastocyst, Cell lineage

G. Christopher Cutler

Professor and Associate Dean Research, Dalhousie University

Interests in Agricultural Entomology and Ecotoxicology

Subrata Deb

Dr. Subrata Deb is Chair & Associate Professor in the Department of Pharmaceutical Sciences at Larkin University, United States. Previous to this, he held positions at the Roosevelt University, The University of British Columbia and Tripura University.

Dr. Deb received his Bachelor of Pharmacy degree from the Berhampur University and his Master of Pharmaceutical Sciences from the University of Mumbai. He received his Ph.D. in Pharmaceutical Sciences from The University of British Columbia and subsequently completed his postdoctoral fellowship from the Vancouver Prostate Centre, a National Centre of Excellence.

Dr. Deb’s primary research interests include Pharmacology, Toxicology, Pharmacogenomics, and Pharmacokinetics with special emphasis on Drug Metabolism and Drug Interactions.

Tushar K. Dutta

I am a Senior Scientist at the Indian Agricultural Research Institute, involved in pursuing basic and applied research in the field of Nematology and Entomology.

As an alternative to Bt Cry toxins for insect pest management, a number of novel bacterial protein toxins (Txp40, TcaB) derived from an insect-parasitic bacterium Photorhabdus akhurstii (symbiont of nematode Heterorhabditis indica) were characterized. The mode of action and pathogenesis process of these toxins were investigated in different lepidopteran insects including Galleria mellonella, Helicoverpa armigera, Spodoptera litura and S. exigua. The potential receptor proteins and their binding sites for these toxins were unravelled from the insect midgut epithelial cells.

My other research interests include molecular basis of plant-nematode interaction. Using RNAi, functional analysis of several plant parasitism processes was deciphered including the role of Mi-cpl-1 in metabolic process, FLP and NLP neuropeptides in neuromusculation process, ODR and TAX proteins in chemotaxis process, cell wall degrading enzymes and various MSP effectors in infection process of plant nematodes. I have contributed in understanding the genetic basis of nematode resistance in rice via genome-wide association mapping coupled with omics-driven strategies. I am currently pursuing genome editing research for developing nematode resistance by adopting CRISPR-Cas9 strategy in Arabidopsis, rice and tomato.